NCT03864887

Brief Summary

This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 11, 2019

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

March 6, 2019

Status Verified

March 1, 2019

Enrollment Period

6 months

First QC Date

March 1, 2019

Last Update Submit

March 5, 2019

Conditions

Keywords

Brain deathOxygen metabolismNear infrared spectroscopy

Outcome Measures

Primary Outcomes (2)

  • Δ[HbO2]

    The changes of oxyhemoglobin concentrations in prefrontal cortex.

    1 day during the whole experiment

  • Δ[Hb]

    The changes of deoxyhemoglobin concentrations in prefrontal cortex.

    1 day during the whole experiment

Secondary Outcomes (2)

  • Heart rate

    1 day during the whole experiment

  • Blood pressure

    1 day during the whole experiment

Study Arms (4)

Brain death patients for HLH Oxygen

Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of high-low-high procedureDevice: Optical monitor for hemodynamic parameter.

Brain death patients for LHL Oxygen

Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of low-high-low procedureDevice: Optical monitor for hemodynamic parameter.

Healthy people for HLH Oxygen

Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of high-low-high procedureDevice: Optical monitor for hemodynamic parameter.

Healthy people for LHL Oxygen

Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

Procedure: Oxygen supply of low-high-low procedureDevice: Optical monitor for hemodynamic parameter.

Interventions

The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).

Brain death patients for HLH OxygenHealthy people for HLH Oxygen

The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).

Brain death patients for LHL OxygenHealthy people for LHL Oxygen

Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Brain death patients for HLH OxygenBrain death patients for LHL OxygenHealthy people for HLH OxygenHealthy people for LHL Oxygen

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult individuals of any gender. Mostly hired in the City of Tianjin, P.R.China

You may qualify if:

  • Patients who have had brain death or serious brain trauma.
  • Healthy people who are interested in optical assessment of hemodynamic parameters

You may not qualify if:

  • Patients who are in pregnancy or have plan to conception.
  • Patients who have vertebra surgery or have plan of surgery.
  • Patients who are inappropriate to join this trial judged by the radiologists or specialists.
  • AIDS, Active Hepatitis, Tuberculosis, Syphilis
  • Patients who regularly take anticoagulants, antiplatelet drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NIRS assessment for brain death

Tianjin, Tianjin Municipality, 300000, China

RECRUITING

MeSH Terms

Conditions

Brain Death

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professer

Study Record Dates

First Submitted

March 1, 2019

First Posted

March 6, 2019

Study Start

February 11, 2019

Primary Completion

August 1, 2019

Study Completion

December 31, 2019

Last Updated

March 6, 2019

Record last verified: 2019-03

Locations